L26/P-396 Fertility preservation (FP) strategies and long-term reproductive outcomes in women with breast cancer
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Bourdon und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Study question What FP strategies are used in women with breast cancer, and what are the long-term reproductive outcomes? Summary answer Most patients underwent controlled ovarian stimulation FP. After ≥5 years, nearly half attempted pregnancy and 60% achieved a live birth, mostly through spontaneous conception. What is known already FP is increasingly integrated into the management of women with breast cancer, whose treatments may impair fertility. Several FP options exist, including controlled ovarian stimulation (COS), in vitro maturation (IVM), and ovarian tissue cryopreservation (OTC), but the optimal approach remains debated, particularly with respect to oncologic timing, treatment urgency, hormone sensitivity, and gonadotoxicity. Real-life data on pregnancy and live birth outcomes, and the utilization of cryopreserved material remain limited. Study design, size, duration Single-centre retrospective cohort study including women aged 18–40 years referred for FP counseling between 2015 and 2019 at a tertiary care centre. Participants/materials, setting, methods FP strategies comprised controlled ovarian stimulation (COS) or in vitro maturation (IVM) with oocyte and/or embryo vitrification, and ovarian tissue cryopreservation (OTC), used alone or in combination. Long-term follow-up (≥5 years) assessed ovarian function, pregnancy intention, conception modalities, and reproductive outcomes. Data on fertility preservation procedures, ovarian reserve, menstrual function, and reproductive outcomes were collected from medical records and follow-up assessments. Main results and the role of chance A total of 165 patients were included (mean age 33.2 ± 3.9 years). Chemotherapy was administered as adjuvant setting in 47.3% (n = 78) and as neoadjuvant setting in 41.2% (n = 68) of patients, while 11.5% (n = 19) did not receive chemotherapy. A FP strategy was proposed to 151 patients (91.5%) and performed in 123 (74.5%). COS was the most frequently used technique (40,6 %), followed by IVM (33,3 %) and OTC (5,4%). Forty-two patients (25.5%) did not undergo FP. Long-term follow-up (>5 years) was available for 94 patients (57.0%). Among them, 45 (47.9%) reported an attempt to conceive. 64.4% (29/45) achieved a clinical pregnancy and 60.0% (27/45) achieved a live birth. Of the 27 women with a live birth, 18 (66.7%) conceived spontaneously, whereas 9 (33.3%) achieved a live birth using assisted reproductive technologies (ART). Cryopreserved material was used by 9 women (9/45, 20.0%) resulting in 2 live births. Compared with women without a pregnancy intention, women who reported an attempt to conceive more frequently had hormone receptor negative disease, received less adjuvant chemotherapy, and more often reported regular cycles; embryo cryopreservation was also more frequent. Limitations, reasons for caution Single-centre design, loss to follow-up, incomplete long-term ovarian reserve data, self-reported outcomes, and absence of a control group may limit generalizability and introduce bias. Wider implications of the findings FP is feasible in women with breast cancer. Despite exposure to potentially gonadotoxic treatments, pregnancy and live birth remain achievable, most often spontaneously. These findings highlight the need for systematic fertility counseling and long-term follow-up to tailor FP strategies. Trial registration number No
Zitieren
APA
Bourdon, M., Weinstein, C., Lange, V. B., Coussy, F., Melka, L., Maignien, C., Gonnot, J., Cheriet, K. P., Chapron, C., & Santulli, P. (2026). L26/P-396 Fertility preservation (FP) strategies and long-term reproductive outcomes in women with breast cancer. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.730
Vancouver
Bourdon M, Weinstein C, Lange VB, Coussy F, Melka L, Maignien C, et al. L26/P-396 Fertility preservation (FP) strategies and long-term reproductive outcomes in women with breast cancer. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.730
BibTeX
@article{Bourdon2026,
author = {Bourdon, M. and Weinstein, C. and Lange, V. Barraud and Coussy, F. and Melka, L. and Maignien, C. and Gonnot, J. and Cheriet, K. Pocate and Chapron, C. and Santulli, P.},
title = {L26/P-396 Fertility preservation (FP) strategies and long-term reproductive outcomes in women with breast cancer},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.730}
}
EUVIMED